ArticleBMC women's health2025
Uterine transverse diameter and risk of LNG-IUS malposition in adenomyosis patients: a threshold effect analysis from a retrospective cohort study.
Article in BMC women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThe malposition of the levonorgestrel-releasing intrauterine system (LNG-IUS) can have a considerable impact on the treatment outcomes for patients with adenomyosis. This study was designed to explore the relationship between the transverse diameter of the uterus and the occurrence of LNG-IUS malposition.
methodsThis retrospective cohort study enrolled 99 adenomyosis patients treated at Fujian Maternity and Child Health Hospital between May 2021 and May 2023. Preoperative uterine transverse diameter was measured using transvaginal ultrasound examinations. We defined LNG-IUS malposition as either downward displacement or expulsion of the device. Data analysis employed Cox regression models with adjustments for relevant demographic, clinical, and laboratory variables.
resultsOur analysis revealed a notable non-linear relationship between the transverse diameter of the uterus and subsequent risk of LNG-IUS malposition. We identified 5.4 cm as a significant clinical threshold; beyond this measurement, the risk increased substantially, with malposition hazard rising by 112% per additional centimeter (HR 2.12; 95% CI, 1.28-3.49; p = 0.003). Among the subgroup of patients suffering from severe dysmenorrhea (VAS ≥ 7), this association was considerably stronger, yielding a hazard ratio of 3.43 (95% CI, 1.32-8.89; p = 0.011).
conclusionPatients with adenomyosis whose uterine transverse diameter exceeds 5.4 cm face a higher risk of LNG-IUS malposition. This measurement threshold provides clinicians a practical tool for assessing suitable candidates for LNG-IUS placement, which may lead to better outcomes in this patient group.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.